Medicare utilization — DR. DOUGLAS W. PURYEAR (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | 5,910 | 24 | $0 | $177,858 |
| J2182 | Injection, mepolizumab, 1 mg | 3,300 | 17 | $0 | $76,837 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 728 | 595 | $0 | $45,709 |
| J0517 | Injection, benralizumab, 1 mg | 630 | 13 | $0 | $84,112 |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 406 | 53 | $0 | $18,415 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·